Anamika Dhyani
Manaus, AM 69050010, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pharmacological assessment of the antineoplastic and immunomodulatory properties of a new spiroindolone derivative (7',8'-Dimethoxy-1',3'-dimethyl-1,2,3',4'-tetrahydrospiro[indole-3,5'-pyrazolo[3,4-c]isoquinolin]-2-one) in chronic myeloid leukemia.
Journal: Investigational new drugs
Published: May 09, 2023
Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases.
Journal: BioMed research international
Published: August 08, 2020
ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells.
Journal: Blood cells, molecules & diseases
Published: March 31, 2020
Anticancer and Immunomodulatory Activities of a Novel Water-Soluble Derivative of Ellipticine.
Journal: Molecules (Basel, Switzerland)
Published: March 23, 2020
Molecular Characterization of Chryseobacterium indologenes with Multidrug Resistance in the Brazilian Amazon Region.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: December 27, 2018
Epidemiological, clinical, and severity characterization of sickle cell disease in a population from the Brazilian Amazon.
Journal: Hematology/oncology and stem cell therapy
Published: July 18, 2018
ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 06, 2014
ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells.
Journal: FEBS letters
Published: August 08, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026